Fertility Tourism Market Size and Share Analysis - Growth Trends and Forecasts (2025-2032)

Market Size and Trends

The Fertility Tourism market is estimated to be valued at USD 5.6 billion in 2025 and is expected to reach USD 12.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.8% from 2025 to 2032. This robust growth is driven by increasing infertility rates globally, advancements in reproductive technologies, and the rising acceptance of medical travel as a viable option for affordable and high-quality fertility treatments.

Key market trends include the growing preference for cross-border fertility services due to cost advantages and varied legal regulations across countries. Additionally, the integration of cutting-edge technologies like IVF automation and genetic screening is enhancing treatment success rates, thereby attracting more international patients. Moreover, expanding awareness and improved accessibility to fertility treatments via digital platforms are further propelling market growth in this segment.

Segmental Analysis:

By Treatment Type: In-vitro Fertilization (IVF) as the Primary Growth Driver

In terms of By Treatment Type, In-vitro Fertilization (IVF) contributes the highest share of the fertility tourism market owing to its wide applicability and high success rates compared to other fertility treatments. IVF has become a preferred choice for couples facing various infertility challenges, including blocked fallopian tubes, severe male factor infertility, or unexplained infertility where other treatments may have failed. The advanced technological progress in IVF techniques, such as improved embryo freezing, genetic screening, and personalized stimulation protocols, has significantly enhanced the chances of successful pregnancies, making IVF highly attractive for international patients seeking effective treatment solutions abroad. Additionally, many countries offering fertility tourism have established robust regulatory frameworks and ethical standards around IVF, emphasizing safety and success outcomes, which further boosts confidence among prospective patients. The relative accessibility and availability of IVF treatment packages at competitive costs in well-developed medical tourism hubs also propel this segment's dominance. Policies that permit single women and LGBTQ+ couples to access IVF services in certain countries add to the expanding patient pool. Moreover, the emotional and social significance attached to IVF's ability to enable biological parenthood reinforces its status as the leading treatment choice within the fertility tourism landscape.

By Patient Type: Domestic Patients Leading Market Participation

Considering the By Patient Type segmentation, domestic patients contribute the highest share of the fertility tourism market. This trend can be largely attributed to increasing awareness and delayed parenthood patterns seen within home countries, where infertility rates are rising due to factors such as lifestyle changes, advanced maternal age, and environmental influences. Domestic patients often seek fertility care beyond their immediate locality but within familiar cultural and regulatory environments, which helps reduce travel-related anxiety and logistics complexities. Moreover, rising healthcare costs and limited availability of specialized fertility services in regional centers prompt domestic patients to explore fertility tourism options within their own countries or neighboring regions. The preference for domestic treatment also hinges on the ease of follow-up care, personalized consultations, and legal protections related to parentage and treatment. Governments and local healthcare systems in many markets have begun promoting fertility clinics and specialty centers domestically to meet demand, encouraging patients to choose nearby destinations with accredited services. Additionally, the trust placed in familiar healthcare professionals combined with growing insurance coverage or subsidy availability contributes to the dominance of domestic patients in fertility tourism. This segment benefits from a balance of treatment affordability, quality, and cultural compatibility that makes domestic travel for fertility treatment highly compelling.

By End-User: Fertility Clinics as the Preferred Facility Type

In terms of By End-User segmentation, fertility clinics hold the predominant share in the fertility tourism market. Fertility clinics are uniquely positioned to drive this segment's growth due to their specialized focus on reproductive technologies and comprehensive services tailored to infertility treatment. These clinics often provide a one-stop solution—from initial diagnostics to advanced reproductive procedures like IVF, IUI, and egg or sperm donation—enabling a seamless patient experience. Their expertise in handling complex cases, access to cutting-edge technology, and dedicated reproductive health teams build significant patient confidence globally. Furthermore, fertility clinics typically offer personalized treatment plans, counseling support, and continuity of care, which are critical factors for patients undergoing emotionally and physically taxing fertility treatments. Their operational model is frequently more flexible and patient-friendly compared to larger hospitals, allowing for customized service packages that appeal to international and domestic patients alike. Many fertility clinics actively engage in marketing and partnership strategies that enhance their visibility and accessibility in the medical tourism domain. Regulatory environments in key source and destination countries often recognize fertility clinics as centers of excellence, granting them accreditation that reassures patients of quality standards. The clinics' agility in adopting new medical innovations and tailoring services to diverse patient needs strengthens their dominance as the preferred end-user segment in fertility tourism.

Regional Insights:

Dominating Region: Europe

In Europe, the fertility tourism market holds a dominant position driven by a favorable healthcare ecosystem, advanced medical infrastructure, and progressive regulatory frameworks supporting assisted reproductive technologies (ART). Many European countries, such as Spain and the Czech Republic, have become hubs due to their liberal laws regarding egg donation, surrogacy, and embryo freezing, attracting international patients seeking high-quality yet relatively more affordable treatment. The strong presence of experienced fertility clinics, coupled with government oversight ensuring safety and ethical standards, reinforces trust in this region. Trade dynamics also favor Europe, with easy travel access for patients from neighboring regions and established medical tourism networks. Notable companies such as IVI Group (Spain) and Reprofit International (Czech Republic) have significantly contributed by expanding clinic networks and offering innovative fertility solutions, thus sustaining Europe's lead in the fertility tourism market.

Fastest-Growing Region: Asia Pacific

Meanwhile, the Asia Pacific region exhibits the fastest growth in fertility tourism, primarily due to the burgeoning middle-class population, increasing infertility rates, and improving ART facilities alongside cost advantages. Countries like India, Thailand, and Malaysia are pivotal in this growth, offering a blend of advanced clinical services with lower procedural costs compared to Western counterparts. Supportive government policies encouraging medical tourism combined with aggressive marketing campaigns have attracted sizable inflows of international patients. Additionally, improvements in healthcare infrastructure, private sector investments, and collaboration with global fertility experts have enhanced service quality and capacity. Leading fertility centers such as the Cloudnine Fertility (India), Bangkok IVF Center (Thailand), and Subang Jaya Medical Centre (Malaysia) have played vital roles by integrating cutting-edge technologies and patient-centric care models, thereby accelerating market expansion in the region.

Fertility Tourism Market Outlook for Key Countries

Spain

Spain's market remains a global magnet for fertility tourism, largely due to its progressive reproductive laws that permit egg donation and embryo research, which many other countries restrict. The country's well-established network of fertility clinics, including leaders like IVI Fertility and Ginemed, provides a wide range of services from IVF to donor programs. Spain's accessibility and multilingual service offerings enhance patient experience, drawing patients from Europe and beyond. The nation's reputation for high treatment success rates and ethical standards under stringent government oversight cement its pivotal role in the fertility tourism landscape.

Czech Republic

The Czech Republic continues to lead in Central Europe by combining affordable treatment costs with advanced reproductive technologies and liberal legal frameworks that support fertility tourism. Clinics such as Reprofit and Gynem specialize in donor insemination and egg donation, attracting patients from Western Europe where fertility treatments might be more restrictive or expensive. The country's strategic location and integration with European healthcare norms foster seamless medical travel, while the presence of English-speaking medical professionals boosts accessibility for international clientele.

India

India's fertility tourism market is rapidly growing, supported by a robust private healthcare system and significant cost advantages. With hospitals like Cloudnine Fertility and Nova IVF specializing in reproductive treatments, India attracts patients seeking affordable yet quality ART services. The government's encouragement of medical tourism through policy initiatives and visa facilitation assists in patient inflows. Moreover, India's expertise in surrogate motherhood, coupled with the availability of comprehensive fertility packages that include travel and accommodation, positions it as a strong contender in the global market.

Thailand

Thailand has emerged as a leading hub in Southeast Asia by leveraging excellent healthcare infrastructure, hospitality services, and competitive pricing. Renowned centers such as Bangkok IVF Center and Jetanin Institute offer comprehensive fertility treatments, including IVF and surrogacy, catering largely to international patients from Australia, Japan, and the Middle East. The government's proactive promotion of medical tourism, alongside streamlined processes and international accreditation of fertility clinics, supports Thailand's growing reputation in this sector.

United States

The United States continues to influence the fertility tourism market through its cutting-edge medical technologies, renowned fertility specialists, and a wide choice of treatment options. Clinics like CCRM and Shady Grove Fertility contribute to innovation in fertility care, including genetic testing and personalized treatment regimes. However, the relatively high cost of treatment and complex regulatory environments encourage many international patients to consider outbound fertility tourism. Despite this, the U.S. remains a key destination for those seeking access to the highest standards of care and the latest ART innovations.

Market Report Scope

Market Segmentation

Treatment Type Insights (Revenue, USD, 2020 - 2032)

• In-vitro Fertilization (IVF)
• Intrauterine Insemination (IUI)
• Surrogacy
• Egg and Sperm Donation
• Others

Patient Type Insights (Revenue, USD, 2020 - 2032)

• Domestic Patients
• International Patients

End-user Insights (Revenue, USD, 2020 - 2032)

• Fertility Clinics
• Hospitals
• Specialty Centers
• Others

Regional Insights (Revenue, USD, 2020 - 2032)

• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa

Key Players Insights

• IHH Healthcare Berhad
• Vitrolife AB
• ACUREN Fertility Group
• Progyny Inc.
• Care Fertility Group
• Boston IVF
• IVI-RMA Global
• Bourn Hall Clinic
• Genea Limited
• Shady Grove Fertility
• Reprofit International
• CREATE Fertility
• Extend Fertility Clinics
• Fertility Centers of Illinois
• New Hope Fertility Center
• Concept Fertility Group
• The Bridge Clinic
• Bay IVF Fertility Center
• Oasis Fertility
• Lister Fertility Clinic